Metformin Does not Affect Outcomes in Patients With Locally Advanced Rectal Cancer Treated With Neoadjuvant Therapy and Resection.
Swati SonalChloe BoudreauHiroko KunitakeRobert N GoldstoneGrace C LeeChristy E CauleyLiliana G BordeianouTodd D FranconeRocco RicciardiDavid L BergerPublished in: The American surgeon (2023)
Metformin does not affect long-term survival in LARC treated with neoadjuvant therapy followed by surgical resection. Studies with larger sample sizes are needed to validate the findings further.